Market revenue in 2023 | USD 2,757.6 million |
Market revenue in 2030 | USD 6,320.6 million |
Growth rate | 12.6% (CAGR from 2023 to 2030) |
Largest segment | Transdermal patches |
Fastest growing segment | Drug Eluting Stents |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Photodynamic Therapy Devices, Transdermal Patches, Wound Care Products, Infusion Pumps, Orthopedic Combination Products, Drug Eluting Stents, Inhalers, Antimicrobial Catheters |
Key market players worldwide | Abbott Laboratories, Terumo Corp, Stryker Corp, Viatris Inc, Medtronic PLC, Boston Scientific Corp, Novartis AG ADR, Becton Dickinson & Co, Teleflex Inc, W L Gore & Associates |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug device combination products market will help companies and investors design strategic landscapes.
Transdermal patches was the largest segment with a revenue share of 22.9% in 2023. Horizon Databook has segmented the Denmark drug device combination products market based on photodynamic therapy devices, transdermal patches, wound care products, infusion pumps, orthopedic combination products, drug eluting stents, inhalers, antimicrobial catheters covering the revenue growth of each sub-segment from 2018 to 2030.
The increasing prevalence of chronic diseases, such as cardiovascular disorders, diabetes, and painrelated conditions, is expected to drive the demand for drug-device combination products in Denmark. Moreover, the rising adoption of self-administration methods for chronic conditions, which allows patients to manage their medication independently and conveniently without frequent visits to healthcare providers, is another factor expected to propel market growth.
According to a research paper published by the European Journal of Public Health in 2023, around 32% of the population in the Capital Region of Denmark self-reported chronic pain, with a higher prevalence among women (35%) than men (28%) and an increase in chronic pain with age, with 20% of individuals aged 16-34 years reporting chronic pain.
This growing demand for advanced and patient-centric drug delivery solutions aligns with the evolving patient preferences for convenient and less invasive treatment options, propelling the drug device combination products market growth in Denmark.
Horizon Databook provides a detailed overview of country-level data and insights on the Denmark drug device combination products market , including forecasts for subscribers. This country databook contains high-level insights into Denmark drug device combination products market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account